Dynamic systemic immune-inflammation index predicts survival after neoadjuvant immunotherapy in gastric cancer: A multicenter study

Summary: The systemic immune-inflammation index (SII), derived from platelet, neutrophil, and lymphocyte counts in peripheral blood, is linked to prognosis in several cancers. We evaluated whether changes in SII during neoadjuvant therapy could predict treatment outcomes in gastric cancer. A total o...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Hua-Long Zheng, Li-Li Shen, Chen-bin Lv, Jia Lin, Bin-bin Xu, Zhen Xue, Jun Lu, Zhi-Wei Zheng, Chang-Ming Huang, Jia-bin Wang, Chao-Hui Zheng
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2026-05-01
Sarja:	iScience
Aiheet:	Oncology Therapeutics
Linkit:	http://www.sciencedirect.com/science/article/pii/S2589004226009879
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!